Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q2Scopus Q1KCI Q1
- 저널
- JOURNAL OF KOREAN MEDICAL SCIENCE38(30) · 2023
- 피인용
- Web of Science 15Scopus 15KCI 1
- FWCI (Scopus)
- 1.93
- JCR IF
- JCR 2022 4.5
- ISSN
- 1011-8934
저자
- Choe, Young June제1저자고려대학교, Department of Pediatrics, KO
- Choi, Eun Hwa교신저자서울대학교, Department of Pediatrics, KO
- Choi, Jong Woon분당제생병원, Bundang Jesaeng General Hospital, KO
- Eun, Byung Wook을지대학교, Department of Pediatrics, KO
- Eun, Lucy Youngmin연세대학교, Department of Laboratory Medicine, KO
- Kim, Yae Jean성균관대학교, Department of Pediatrics, KO
- Kim, Yeo Hyang경북대학교, Department of Pediatrics, KO
- 김영아부산대학교, 의과대학, 의학과, KO
- Kim, Yun Kyung고려대학교, Department of Pediatrics, KO
- Kwak, Ji Hee경북삼성병원, Department of Pediatrics, KO
- Lee, Hyukmin연세대학교, Department of Laboratory Medicine, KO
- Park, June Dong서울대학교, Department of Pediatrics, KO
- Jung, Yeon Haw연세대학교, Department of Laboratory Medicine, KO
- Gwack, Jin질병관리청, Korea Disease Control and Prevention Agency, KO
- Lee, Sangwon질병관리청, Korea Disease Control and Prevention Agency, KO
초록
BACKGROUND: There is difference in the incidence of multi-system inflammatory syndrome in children (MIS-C) in patients with different variants of severe acute respiratory syndrome coronavirus 2, however, little is known about the epidemiology in Asian countries. We investigated and compared the epidemiology of the MIS-C during omicron-dominant period with that of previous periods in South Korea. METHODS: We obtained clinical, epidemiological and laboratory data on MIS-C cases from national MIS-C surveillance in South Korea. We defined pre-delta period as January 2020-May 2021; delta period as June 2021-December 2021; and omicron period as January 2022-April 2022. We describe the clinical characteristics and outcomes of MIS-C patients by period. RESULTS: A total of 91 cases were assessed to be MIS-C cases. Number of MIS-C cases have increased from six cases during pre-delta period to 66 cases during omicron period, while the incidence rate (the number of MIS-C cases per 100,000 cases of reported coronavirus disease 2019) has decreased from 38.5 cases per 100,000 (95% confidence interval [CI], 14.1-83.9) during pre-delta period to 1.6 cases per 100,000 (95% CI, 1.2-2.0) during omicron periods. During pre-delta period, 66.7% and 100% had hypotension and gastrointestinal involvement, respectively; while during omicron period, 12.1% and 6.1% had such clinical manifestations. Fifty percent of pre-delta MIS-C patients were taken intensive care unit (ICU) cares, while 10.6% of patients during omicron periods were in ICUs. CONCLUSION: Omicron period were associated with less severe clinical manifestation compared to pre-delta and delta periods. Although incidence rate of MIS-C was lower for the omicron period than pre-delta and delta periods, number of patients reported with MIS-C may pose a substantial clinical burden.
키워드
COVID-19MIS-CSARS-CoV-2MULTISYSTEM INFLAMMATORY SYNDROMEOMICRON VARIANTSOUTH-KOREADISEASECHILDRENSURVEILLANCEVACCINE
식별자
- Scopus EID
- 2-s2.0-85166105269
- WoS UID
- 001043974700004
- KCI
- ART002983510



로그인
연구물 목록으로